IBOV 171,031.73 ▲ 1.85% IPSA 11,338.38 ▲ 0.89% IPC MEX 65,729.18 ▲ 2.14% MERVAL 2,913,184 ▲ 1.30% COLCAP 2,459.23 ▲ 0.61% BVL PERÚ 58,698.13 ▲ 2.60% USD/BRL5.14▼ 0.05% USD/MXN16.89▼ 0.10% USD/CLP914.28▼ 0.08% USD/COP3,043▲ 0.15% USD/PEN3.35▼ 0.06% USD/ARS1,499▼ 0.03% USD/UYU40.20▲ 1.52% USD/PYG5,996▲ 1.39% USD/BOB11.43▲ 0.51% USD/DOP58.82▲ 0.19% USD/CRC450.05▲ 1.95% USD/GTQ7.62▲ 2.13% USD/HNL26.81▲ 1.55% USD/NIO36.62— 0.00% USD/VES782.70▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD 157.28 — 0.00% USD/TTD6.71▲ 0.82% EUR/BRL6.00▼ 1.08% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73% IBOV 171,031.73 ▲ 1.85% IPSA 11,338.38 ▲ 0.89% IPC MEX 65,729.18 ▲ 2.14% MERVAL 2,913,184 ▲ 1.30% COLCAP 2,459.23 ▲ 0.61% BVL PERÚ 58,698.13 ▲ 2.60% USD/BRL 5.16 ▲ 0.01% USD/MXN 17.06 ▼ 0.24% USD/CLP 913.98 ▲ 0.04% USD/COP 3,140 ▲ 0.03% USD/PEN 3.36 ▼ 0.66% USD/ARS 1,493 ▲ 0.10% USD/UYU 40.27 ▲ 1.24% USD/PYG 5,939 ▲ 1.68% USD/BOB 11.64 ▼ 0.76% USD/DOP 58.34 ▲ 1.25% USD/CRC 445.92 ▲ 0.89% USD/GTQ 7.62 ▲ 2.21% USD/HNL 26.79 ▲ 1.57% USD/NIO 36.62 ▲ 0.69% USD/VES 762.44 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.28 — 0.00% USD/TTD 6.70 ▲ 0.61% EUR/BRL 5.95 ▲ 1.01% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73%
since 2009
Sunday, August 23, 2026

Covid-19 Brazil

Butantan “Project S” shows pandemic can be controlled if 75% of population is vaccinated

By · May 31, 2021 · 3 min read

Daily Brief

The morning intel from across Latin America. Free.

By subscribing you agree to our privacy policy. We never share your email.

RIO DE JANEIRO, BRAZIL – The coronavirus pandemic can be controlled if 75% of the population is vaccinated against Covid-19, according to a study carried out in a Brazilian city, where its inhabitants were massively immunized with the CoronaVac vaccine from the Chinese laboratory Sinovac, the Butantan Institute reported this Monday, May 31.

According to the study, the first of its kind to be carried out in the world, deaths fell by 95% after mass vaccination, hospitalizations dropped by 86%, and symptomatic cases were reduced by 80%.

Pandemic can be controlled if 75% of the population is vaccinated, says Brazilian study
Pandemic can be controlled if 75% of the population is vaccinated, says a Brazilian study. (Photo internet reproduction)
One-stop reference
Company Intelligence
Every listed company in Latin America — financials, ownership and structure for 1,450+ companies across 26 exchanges, in one place.
Browse the directory →
RT
Ask Rio Times
This story and the bigger picture.
Open the full Ask Rio Times →

The experiment also revealed that minors would not need to be immunized, because of the indirect effects of the vaccine.

The project took place in Serrana, a town located near Ribeirão Preto, some 200 km north of the state capital and home to 45,000 inhabitants, of whom about 30,000 over 18 years of age were immunized with the Chinese vaccine between February 17 and April 11.

Serrana was chosen for the study because it is a low-population city with high rates of Covid-19 infection.

One and a half months after the completion of the vaccination process in Serrana, the Butantan Institute, one of the most prestigious medical research centers in Brazil and Latin America, linked to the government of São Paulo and in charge of the manufacture of the Coronavac vaccine in Brazil, presented the conclusions on Monday at a press conference.

The so-called “Project S” (Serrana Project) vaccination process lasted four weeks, and in each of them, a group of adults was immunized. Control of the pandemic in the municipality was achieved when 75% of its population received the two doses of the Chinese immunizer, the study concluded.

Those responsible for the study compared the data from the beginning of the project – until the vaccination of all groups was completed – with the rest of the evaluated quarter (February, March, and April 2021).

The data show that on February 16, one day before the mass vaccination process, this municipality had 57 deaths and 2,499 confirmed cases of the virus.

After immunization, cases dropped to 699 in March and 251 in April. Deaths plummeted from 30 to 6 in the same period.

The results also showed that the vaccination protects both adults who received the two doses of the Chinese immunizer and children and adolescents under 18 years of age who were not vaccinated.

As explained by the director of clinical trials of the Butantan Institute, Ricardo Palacios, the immunization generated a sort of “immune belt” in Serrana, “drastically reducing” the transmission of the virus in the municipality.

“The most important result was to understand that we can control the pandemic even without vaccinating the entire population. When 70% to 75% coverage was reached, the drop in incidence was noticed even in the last group that had not yet completed the vaccination schedule,” he said. “It will not be necessary to vaccinate minors,” he specified.

For the general director of the Butantan Institute, Dimas Covas, this shows that the CoronaVac vaccine “is safe, effective and efficient” and contributes to preventing the development of the disease, complications, and deaths among those infected.

“We now also know that it has a beneficial effect on the entire population, protecting both vaccinated and unvaccinated people and significantly reducing viral circulation,” he added.

This article was produced by The Rio Times’ automated newsroom system. How we use AI · Report an error

Read More from The Rio Times

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.